Search
Use the filters to narrow by type of content
Looking for a Publication? Search the bibliography for: news events icpe all access 2020
… transparent, and user-friendly, which is why we staff all projects with senior researchers and modelers who have …
… and researchers (RTI-HS and another investigator). In all, studies were carried out over 18 years using different … in a 15-year US postmarketing surveillance study . JBMR, 2020, pp 1-8; doi: 10.1002/jbmr.4188 Gilsenan AW , Midkiff … state cancer registry data . Pharmacoepidemiol Drug Saf, 2020;1-11; doi: 10.1002/pds.5103 Midkiff KD , Andrews EB , …
… they can also help with diagnosis and regular monitoring, all of which can improve patient outcomes. Biopharma can use … the generalizability of study results and improving access to life-saving treatments for all members of the population. Strategies to reach …
RTI-HS researcher to lead study that will seek perspectives of those affected by Alzheimer’s Share on: May 22, 2018 Understanding What Matters Most to Alzheimer's patients and their caregivers to help inform the drug development process. The Alzheimer’s …
… a resource for advancing epidemiological knowledge at all levels. We regularly participate as speakers at top …
Navigating EU Joint Clinical Assessments and Joint Scientific Consultations From January 2025 Onward
… transparency, and timeliness of clinical HTAs so that access to innovative medicines is accelerated for EU … the submission is subject to the EU HTAR, which applies to all new oncology drugs and cell and gene therapies from … orphan medicinal products from January 2028, and lastly, all new drugs from 2030 onward. It also means that the …
… with different sets of benefits and potential adverse events. Treatment attributes are relative based on a person’s … results to inform your drug development and market access strategies. For your project, we conduct the …
… products ahead of FDA approval can help improve patient access to emerging therapies and devices. Work with our team … for formulary submission dossiers. Our team of market access experts has extensive experience developing rigorous …
… KJ, Hernandez-Diaz S. Poster presented at the 34th ICPE International Conference on Pharmacoepidemiology & …
… evidence ratings in evidence reports for new drugs in 2020 and 2021. Ronquest N , Clinkscales M, Paret K. … ratings were reviewed, across 17 assessments published in 2020 and 2021. As part of our analysis, we identified trends …